What is Sanofi?
Sanofi is a pharmaceutical and vaccines company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Pharmaceutical and vaccines company
- Headquarters
- Paris, France
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Euronext/Nasdaq: SNY
What is Sanofi?
Sanofi is a pharmaceutical and vaccines company company headquartered in Paris, France. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Sanofi is a pharmaceutical and vaccines company company headquartered in Paris, France. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Sanofi should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Sanofi offer?
Sanofi's profile centers on Vaccines, Specialty care, General medicines, Immunology.
- Vaccines· Pharmaceutical and vaccines company
- Specialty care· Pharmaceutical and vaccines company
- General medicines· Pharmaceutical and vaccines company
- Immunology· Pharmaceutical and vaccines company
- Rare diseases· Pharmaceutical and vaccines company
- Clinical pipeline· Pharmaceutical and vaccines company
How does Sanofi make money?
Sanofi makes money through commercial activity tied to pharmaceutical and vaccines company.
Sanofi monetizes through the model common to pharmaceutical and vaccines company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Sanofi?
Sanofi's named executives should be verified on the official leadership or investor-relations page before outreach.
- Sanofi executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Sanofi finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Sanofi operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Sanofi's leadership?
Sanofi should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.sanofi.comHow is Sanofi funded?
Sanofi's current status is Public company; Euronext/Nasdaq: SNY.
Sanofi's capital profile is best understood through its current public-company status: Public company; Euronext/Nasdaq: SNY. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Sanofi get here?
Sanofi's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingSanofi is foundedThe company begins building in pharmaceutical and vaccines company.
- Scale-upCommercial footprint expandsSanofi broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Euronext/Nasdaq: SNYPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Sanofi's competitors?
Sanofi competes with larger incumbents and focused specialists in pharmaceutical and vaccines company.
Sanofi — frequently asked questions
